clopidogrel has been researched along with rifampin in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Bates, ER; Carville, DG; Gurbel, PA; Guyer, KE; Hopp, AS; Lau, WC; Neer, CJ; Tait, AR; Watkins, PB | 1 |
| Buckland, RJ; Jakubowski, JA; Judge, HM; Patil, SB; Storey, RF | 1 |
| Ieiri, I; Irie, S; Kim, SJ; Kimura, M; Kusuhara, H; Maeda, K; Sugiyama, Y; Yoshikado, T | 1 |
1 review(s) available for clopidogrel and rifampin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for clopidogrel and rifampin
| Article | Year |
|---|---|
Contribution of hepatic cytochrome P450 3A4 metabolic activity to the phenomenon of clopidogrel resistance.
Topics: Clopidogrel; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Drug Resistance; Humans; Liver; Platelet Aggregation Inhibitors; Rifampin; Ticlopidine | 2004 |
3 other study(ies) available for clopidogrel and rifampin
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Potentiation of clopidogrel active metabolite formation by rifampicin leads to greater P2Y12 receptor blockade and inhibition of platelet aggregation after clopidogrel.
Topics: Adenosine Diphosphate; Adult; Area Under Curve; Blood Platelets; Clopidogrel; Coronary Artery Disease; Drug Administration Schedule; Drug Synergism; Humans; Male; Middle Aged; Platelet Aggregation; Purinergic P2Y Receptor Antagonists; Receptors, Purinergic P2Y12; Rifampin; Ticlopidine | 2010 |
Clarification of the Mechanism of Clopidogrel-Mediated Drug-Drug Interaction in a Clinical Cassette Small-dose Study and Its Prediction Based on In Vitro Information.
Topics: Area Under Curve; Clopidogrel; Cytochrome P-450 CYP2C8; Dose-Response Relationship, Drug; Drug Interactions; Humans; In Vitro Techniques; Male; Platelet Aggregation Inhibitors; Quinolines; Rifampin; Ticlopidine; Trimethoprim | 2016 |